Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 1
2004 3
2005 4
2006 1
2007 3
2008 2
2009 4
2010 3
2011 6
2012 6
2013 2
2014 4
2015 4
2016 4
2017 2
2018 2
2019 1
2020 1
2021 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma.
Younes A, Gopal AK, Smith SE, Ansell SM, Rosenblatt JD, Savage KJ, Ramchandren R, Bartlett NL, Cheson BD, de Vos S, Forero-Torres A, Moskowitz CH, Connors JM, Engert A, Larsen EK, Kennedy DA, Sievers EL, Chen R. Younes A, et al. Among authors: rosenblatt jd. J Clin Oncol. 2012 Jun 20;30(18):2183-9. doi: 10.1200/JCO.2011.38.0410. Epub 2012 Mar 26. J Clin Oncol. 2012. PMID: 22454421 Free PMC article. Clinical Trial.
Regulatory B cells in anti-tumor immunity.
Zhang Y, Gallastegui N, Rosenblatt JD. Zhang Y, et al. Among authors: rosenblatt jd. Int Immunol. 2015 Oct;27(10):521-30. doi: 10.1093/intimm/dxv034. Epub 2015 May 20. Int Immunol. 2015. PMID: 25999597 Review.
CD30: an important new target in hematologic malignancies.
Deutsch YE, Tadmor T, Podack ER, Rosenblatt JD. Deutsch YE, et al. Among authors: rosenblatt jd. Leuk Lymphoma. 2011 Sep;52(9):1641-54. doi: 10.3109/10428194.2011.574761. Epub 2011 May 27. Leuk Lymphoma. 2011. PMID: 21619423 Review.
Present and future of lung cancer vaccines.
Raez LE, Rosenblatt JD, Podack ER. Raez LE, et al. Among authors: rosenblatt jd. Expert Opin Emerg Drugs. 2006 Sep;11(3):445-59. doi: 10.1517/14728214.11.3.445. Expert Opin Emerg Drugs. 2006. PMID: 16939384 Review.
The mevalonate synthesis pathway as a therapeutic target in cancer.
Andela VB, Pirri M, Schwarz EM, Puzas EJ, O'Keefe RJ, Rosenblatt JD, Rosier RN. Andela VB, et al. Among authors: rosenblatt jd. Clin Orthop Relat Res. 2003 Oct;(415 Suppl):S59-66. doi: 10.1097/01.blo.0000093846.72468.66. Clin Orthop Relat Res. 2003. PMID: 14600593 Review.
Potential role of chemokines in immune therapy of cancer.
Rosenblatt JD, Shin SU, Nechustan H, Yi KH, Tolba K. Rosenblatt JD, et al. Isr Med Assoc J. 2002 Nov;4(11):1054-9. Isr Med Assoc J. 2002. PMID: 12489506 Free article. Review. No abstract available.
Antibody-Drug Conjugate αEGFR-E-P125A Reduces Triple-negative Breast Cancer Vasculogenic Mimicry, Motility, and Metastasis through Inhibition of EGFR, Integrin, and FAK/STAT3 Signaling.
Sankar AP, Cho HM, Shin SU, Sneh T, Ramakrishnan S, Elledge C, Zhang Y, Das R, Gil-Henn H, Rosenblatt JD. Sankar AP, et al. Among authors: rosenblatt jd. Cancer Res Commun. 2024 Mar 11;4(3):738-756. doi: 10.1158/2767-9764.CRC-23-0278. Cancer Res Commun. 2024. PMID: 38315147 Free PMC article.
55 results